Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Naghmeh Mokhber, Carol J Lane, Mohamad R Azarpazhooh, Elham Salari, Reza Fayazi, Mohamad T Shakeri & Allan H Young. (2008) Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran. Neuropsychiatric Disease and Treatment 4:1, pages 227-234.
Read now
Read now
Charles L. Bowden & Nancy U. Karren. (2006) Anticonvulsants in bipolar disorder. Australian and New Zealand Journal of Psychiatry 40:5, pages 386-393.
Read now
Read now
Steven F Kendell, John H Krystal & Gerrard Sanacora. (2005) GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opinion on Therapeutic Targets 9:1, pages 153-168.
Read now
Read now
Charles L Bowden & Anupama A Krishnan. (2004) Pharmacotherapy for bipolar depression: an economic assessment. Expert Opinion on Pharmacotherapy 5:5, pages 1101-1107.
Read now
Read now
Kelly C Lee, Patrick R Finley & Brian K Alldredge. (2003) Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opinion on Drug Safety 2:3, pages 233-247.
Read now
Read now
Articles from other publishers (25)
Linda Salzmann, Tino Spescha, Neeraj Singh, Tobias Schierscher, Martina Bachmann, Friederike Bauland, Andrea Geistanger, Lorenz Risch, Christian Geletneky, Christoph Seger & Judith Taibon. (2023) An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the quantification of lamotrigine in human serum and plasma. Clinical Chemistry and Laboratory Medicine (CCLM) 0:0.
Crossref
Crossref
Harold A. Sackeim, Scott T. Aaronson, Mark T. Bunker, Charles R. Conway, Mark A. Demitrack, Mark S. George, Joan Prudic, Michael E. Thase & A. John Rush. (2019) The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). Journal of Psychiatric Research 113, pages 125-136.
Crossref
Crossref
António O.L. Évora, Ricardo A.E. Castro, Teresa M.R. Maria, M. Ramos Silva, João Canotilho & M. Ermelinda S. Eusébio. (2019) Lamotrigine: Design and synthesis of new multicomponent solid forms. European Journal of Pharmaceutical Sciences 129, pages 148-162.
Crossref
Crossref
Francisco López-Muñoz, Winston Shen, Pilar D’Ocon, Alejandro Romero & Cecilio Álamo. (2018) A History of the Pharmacological Treatment of Bipolar Disorder. International Journal of Molecular Sciences 19:7, pages 2143.
Crossref
Crossref
Martha Sajatovic, Sergio A Strejilevich, Ariel G Gildengers, Annemiek Dols, Rayan K Al Jurdi, Brent P Forester, Lars Vedel Kessing, John Beyer, Facundo Manes, Soham Rej, Adriane R Rosa, Sigfried NTM Schouws, Shang-Ying Tsai, Robert C Young & Kenneth I Shulman. (2015) A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. Bipolar Disorders 17:7, pages 689-704.
Crossref
Crossref
Yan Leng, Emily Bame Fessler & De-Maw Chuang. (2013) Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction. International Journal of Neuropsychopharmacology 16:3, pages 607-620.
Crossref
Crossref
Elisa Brietzke, Rodrigo B. Mansur, Rodrigo Grassi-Oliveira, Joanna K. Soczynska & Roger S. McIntyre. (2012) Inflammatory cytokines as an underlying mechanism of the comorbidity between bipolar disorder and migraine. Medical Hypotheses 78:5, pages 601-605.
Crossref
Crossref
Edislav Lekšić, Gordana Pavlović & Ernest Meštrović. (2012) Cocrystals of Lamotrigine Based on Coformers Involving Carbonyl Group Discovered by Hot-Stage Microscopy and DSC Screening. Crystal Growth & Design 12:4, pages 1847-1858.
Crossref
Crossref
Jared W Young, Brook L Henry & Mark A Geyer. (2011) Predictive animal models of mania: hits, misses and future directions. British Journal of Pharmacology 164:4, pages 1263-1284.
Crossref
Crossref
Mariana Bendlin Calzavara, Wladimir Agostini Medrano, Raquel Levin, Tânia Cristina Libânio, Rosana de Alencar Ribeiro & Vanessa Costhek Abílio. (2011) The contextual fear conditioning deficit presented by spontaneously hypertensive rats (SHR) is not improved by mood stabilizers. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:7, pages 1607-1611.
Crossref
Crossref
K.J. Oedegaard, T.A. Greenwood, A. Lunde, O.B. Fasmer, H.S. Akiskal & J.R. Kelsoe. (2010) A genome-wide linkage study of bipolar disorder and co-morbid migraine: Replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11. Journal of Affective Disorders 122:1-2, pages 14-26.
Crossref
Crossref
Miranda L. Cheney, Ning Shan, Elisabeth R. Healey, Mazen Hanna, Lukasz Wojtas, Michael J. Zaworotko, Vasyl Sava, Shijie Song & Juan R. Sanchez-Ramos. (2009) Effects of Crystal Form on Solubility and Pharmacokinetics: A Crystal Engineering Case Study of Lamotrigine. Crystal Growth & Design 10:1, pages 394-405.
Crossref
Crossref
Charles L Bowden. (2009) Anticonvulsants in bipolar disorders: current research and practice and future directions. Bipolar Disorders 11, pages 20-33.
Crossref
Crossref
Charles L. Bowden, Suzanne Edwards & Gary Evoniuk. (2014) Open-Label, Concomitant Use of Lamotrigine and Other Medications for Bipolar Disorder. CNS Spectrums 13:1, pages 75-83.
Crossref
Crossref
G. Laux. 2008. Psychiatrie und Psychotherapie. Psychiatrie und Psychotherapie
1473
1500
.
Benedikt Amann, Heinz Grunze, Eduard Vieta & Michael Trimble. (2016) Antiepileptic Drugs and Mood Stability. Clinical EEG and Neuroscience 38:2, pages 116-123.
Crossref
Crossref
Gabriel Rubio, Francisco Lopez-Munoz & Cecilio Alamo. (2006) Effects of lamotrigine in patients with bipolar disorder and alcohol dependence. Bipolar Disorders 8:3, pages 289-293.
Crossref
Crossref
Charles L. Bowden & Nancy U. Karren. (2006) Anticonvulsants in bipolar disorder. Australian and New Zealand Journal of Psychiatry 40:5, pages 386-393.
Crossref
Crossref
H.-J. Möller, H. Grunze & K. Broich. (2005) Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice?. European Archives of Psychiatry and Clinical Neuroscience 256:1, pages 1-16.
Crossref
Crossref
Akira Kugaya & Gerard Sanacora. (2014) Beyond Monoamines: Glutamatergic Function in Mood Disorders. CNS Spectrums 10:10, pages 808-819.
Crossref
Crossref
Vivek Singh, David J. Muzina & Joseph R. Calabrese. (2005) Anticonvulsants in Bipolar Disorder. Psychiatric Clinics of North America 28:2, pages 301-323.
Crossref
Crossref
James W. Jefferson. (2014) Lamotrigine in Psychiatry: Pharmacology and Therapeutics. CNS Spectrums 10:3, pages 224-234.
Crossref
Crossref
Jari Tiihonen, Tero Hallikainen, Olli-Pekka Ryynänen, Eila Repo-Tiihonen, Irma Kotilainen, Markku Eronen, Päivi Toivonen, Kristian Wahlbeck & Anu Putkonen. (2003) Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial. Biological Psychiatry 54:11, pages 1241-1248.
Crossref
Crossref
GERARD SANACORA, DOUGLAS L. ROTHMAN, GRAEME MASON & JOHN H. KRYSTAL. (2003) Clinical Studies Implementing Glutamate Neurotransmission in Mood Disorders. Annals of the New York Academy of Sciences 1003:1, pages 292-308.
Crossref
Crossref
David R Goldsmith, Antona J Wagstaff, Tim Ibbotson & Caroline M Perry. (2003) Lamotrigine. Drugs 63:19, pages 2029-2050.
Crossref
Crossref